Illumina, headquartered in San Diego, develops life science tools for genetic analysis, employing 10,590 staff since its IPO in 2000. Its products span various applications, including oncology and agriculture.
ILMN has been in the news recently: Illumina, Inc. announced its agreement to acquire Standard BioTools' LAB subsidiary, SomaLogic, on Monday. On the same day, U.S. stocks rose, with the Dow Jones index gaining approximately 50 points.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
